Category: Health & Medicines > Health Care Supplement > Dolutegravir
Country/Region: China State/Province: Shanghai
Main Products: Peptide, Drug Peptide, Peptide Synthesis, Labeled Peptide, Peptide
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2007, 2007
Legal Status: Third Party
Ownership: Corporation Limited Liability Company
Employees: 101 - 200 People
Factory Size: 30, 000-50, 000 square meters
R&D Team Size: 51 - 100 People
Certifications: BSCI
Contact Person: Joe Chen
Designation: Purchasing
Department: Director
Telephone: 021-31208408
Main Markets: New Zealand (22%) Australia (17%) United Kingdom (15%) Germany (13%) Canada (12%)
Export Focus: Australia, Canada, Germany, New Zealand, United Kingdom
Contract Services: Design Service Offered
Annual Revenue: Approx 5 Million US Dollar
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 61% - 70%
Payment Terms: Bank wire (T/T), Doc Against Acceptance (D/A), PayPal, Cash